litlas
ログインアカウント作成

Robert Z. Orlowski

1998–2025 年に発表

199
論文数
46,455
被引用数
102
h 指数
185
i10 指数

被引用数

Robert Z. Orlowski の年別被引用数1987 年: 被引用 1 件1988 年: 被引用 4 件1989 年: 被引用 1 件1990 年: 被引用 1 件1999 年: 被引用 9 件2000 年: 被引用 18 件2001 年: 被引用 16 件2002 年: 被引用 27 件2003 年: 被引用 72 件2004 年: 被引用 159 件2005 年: 被引用 158 件2006 年: 被引用 194 件2007 年: 被引用 191 件2008 年: 被引用 208 件2009 年: 被引用 236 件2010 年: 被引用 223 件2011 年: 被引用 251 件2012 年: 被引用 242 件2013 年: 被引用 309 件2014 年: 被引用 403 件2015 年: 被引用 340 件2016 年: 被引用 386 件2017 年: 被引用 475 件2018 年: 被引用 420 件2019 年: 被引用 1,668 件2020 年: 被引用 1,978 件2021 年: 被引用 1,854 件2022 年: 被引用 1,329 件2023 年: 被引用 954 件2024 年: 被引用 1,585 件2025 年: 被引用 666 件2026 年: 被引用 22 件1991〜1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,998 件、この内訳の 27%中国: 引用元論文 1,400 件、この内訳の 9.5%イタリア: 引用元論文 841 件、この内訳の 5.7%ドイツ: 引用元論文 810 件、この内訳の 5.5%イギリス: 引用元論文 769 件、この内訳の 5.2%フランス: 引用元論文 662 件、この内訳の 4.5%スペイン: 引用元論文 636 件、この内訳の 4.3%カナダ: 引用元論文 461 件、この内訳の 3.1%オランダ: 引用元論文 420 件、この内訳の 2.8%日本: 引用元論文 364 件、この内訳の 2.5%オーストラリア: 引用元論文 346 件、この内訳の 2.3%ギリシャ: 引用元論文 343 件、この内訳の 2.3%
0%27%その他 25.3%

機関

分野

  • Medicine62.8%
  • Biochemistry, Genetics and Molecular Biology30.5%
  • Immunology and Microbiology3.4%
  • Chemistry0.6%
  • Computer Science0.5%
  • Materials Science0.4%
  • その他1.8%

トピック

  • Multiple Myeloma Research and Treatments15.4%
  • Protein Degradation and Inhibitors8%
  • Ubiquitin and proteasome pathways6.7%
  • Peptidase Inhibition and Analysis4.6%
  • CAR-T cell therapy research3%
  • Cancer Treatment and Pharmacology2.3%
  • その他60%

共著者

全論文

検索で開く
  1. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

    著者: Shaji Kumar, Bruno Paiva, Kenneth C. Anderson, Brian G.M. Durie, Ola Landgren, Philippe Moreau, Nikhil C. Munshi, Sagar Lonial, Joan Bladé, María‐Victoria Mateos, Meletios Α. Dimopoulos, Efstathios Kastritis, Mario Boccadoro, Robert Z. Orlowski, Hartmut Goldschmidt, Andrew Spencer, Jian Hou, Wee Joo Chng, Saad Z. Usmani, Elena Zamagni, Kazuyuki Shimizu, Sundar Jagannath, Hans Erik Johnsen, Evangelos Terpos, Tony Reiman, Robert A. Kyle, Pieter Sonneveld, Paul G. Richardson, Philip L. McCarthy, Heinz Ludwig, Wen-Ming Chen, Michèle Cavo, Jean‐Luc Harousseau, Suzanne Lentzsch, Jens Hillengaß, Antonio Palumbo, Alberto Órfão, S. Vincent Rajkumar, Jesús F. San Miguel, Hervé Avet‐Loiseau - The Lancet Oncology 2016 被引用: 2,995

  2. Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

    著者: Antonio Palumbo, Hervé Avet‐Loiseau, Stefania Oliva, Henk M. Lokhorst, Hartmut Goldschmidt, Laura Rosiñol, Paul Richardson, S Caltagirone, Juan José Lahuerta, Thierry Façon, Sara Bringhen, Francesca Gay, Michel Attal, Roberto Passera, Andrew Spencer, Massimo Offidani, Shaji Kumar, Pellegrino Musto, Sagar Lonial, Maria Teresa Petrucci, Robert Z. Orlowski, Elena Zamagni, Gareth J. Morgan, Meletios Α. Dimopoulos, Brian G.M. Durie, Kenneth C. Anderson, Pieter Sonneveld, Jesús F. San Miguel, Michèle Cavo, S. Vincent Rajkumar, Philippe Moreau - Journal of Clinical Oncology 2015 被引用: 2,178

  3. Proteasome inhibitors in cancer therapy

    著者: Elisabet E. Manasanch, Robert Z. Orlowski - Nature Reviews Clinical Oncology 2017 被引用: 1,022

  4. Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial

    著者: Peter M. Voorhees, Jonathan L. Kaufman, Jacob P. Laubach, Douglas W. Sborov, Brandi Reeves, Cesar Rodriguez, Ajai Chari, Rebecca Silbermann, Luciano J. Costa, Larry D. Anderson, Nitya Nathwani, Nina Shah, Yvonne A. Efebera, Sarah A. Holstein, Caitlin Costello, Andrzej Jakubowiak, Tanya M. Wildes, Robert Z. Orlowski, Kenneth H. Shain, Andrew J. Cowan, Séan Murphy, Yana Lutska, Huiling Pei, Jon Ukropec, Jessica Vermeulen, Carla de Boer, Daniela Hoehn, Thomas S. Lin, Paul G. Richardson - Blood 2020 被引用: 690

  5. Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma

    著者: Thierry Façon, Shaji Kumar, Torben Plesner, Robert Z. Orlowski, Philippe Moreau, Nizar J. Bahlis, Supratik Basu, Hareth Nahi, Cyrille Hulin, Hang Quach, Hartmut Goldschmidt, Michael O’Dwyer, Aurore Perrot, Christopher P. Venner, Katja Weisel, Joseph R. Mace, Noopur Raje, Michel Attal, Mourad Tiab, Margaret Macro, Laurent Frenzel, Xavier Leleu, Tahamtan Ahmadi, Christopher Chiu, Jianping Wang, Rian Van Rampelbergh, Clarissa Uhlar, Rachel Kobos, Ming Qi, Saad Z. Usmani - New England Journal of Medicine 2019 被引用: 987

  6. Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma

    著者: Paul G. Richardson, Susanna Jacobus, Edie Weller, Hani Hassoun, Sagar Lonial, Noopur Raje, Eva Medvedova, Philip L. McCarthy, Edward N. Libby, Peter M. Voorhees, Robert Z. Orlowski, Larry D. Anderson, Jeffrey A. Zonder, Carter P. Milner, Cristina Gasparetto, Mounzer Agha, Abdullah Khan, David D. Hurd, Krisstina Gowin, Rammurti T. Kamble, Sundar Jagannath, Nitya Nathwani, Melissa Alsina, Robert F. Cornell, Hamza Hashmi, Erica Campagnaro, Astrid C. Andreescu, Teresa Gentile, Michaela Liedtke, Kelly Godby, Adam D. Cohen, Thomas H. Openshaw, Marcelo C. Pasquini, Sergio Giralt, Jonathan L. Kaufman, Andrew J. Yee, Emma C. Scott, Pallawi Torka, Amy Foley, Mariateresa Fulciniti, Kyle Hebert, Mehmet Samur, Kelly Masone, Michelle E. Maglio, Andrea A. Zeytoonjian, Omar Nadeem, Robert Schlossman, Jacob P. Laubach, Claudia E. Paba‐Prada, Irene M. Ghobrial, Aurore Perrot, Philippe Moreau, Hervé Avet‐Loiseau, Michel Attal, Kenneth C. Anderson, Nikhil C. Munshi - New England Journal of Medicine 2022 被引用: 463

  7. Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial

    著者: Thierry Façon, Shaji Kumar, Torben Plesner, Robert Z. Orlowski, Philippe Moreau, Nizar J. Bahlis, Supratik Basu, Hareth Nahi, Cyrille Hulin, Hang Quach, Hartmut Goldschmidt, Michael O’Dwyer, Aurore Perrot, Christopher P. Venner, Katja Weisel, Joseph R. Mace, Noopur Raje, Mourad Tiab, Margaret Macro, Laurent Frenzel, Xavier Leleu, Tahamtan Ahmadi, Jianping Wang, Rian Van Rampelbergh, Clarissa Uhlar, Brenda Tromp, Maria Delioukina, Jessica Vermeulen, Saad Z. Usmani - The Lancet Oncology 2021 被引用: 363

  8. Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

    著者: S. Vincent Rajkumar, Jean‐Luc Harousseau, Brian G.M. Durie, Kenneth C. Anderson, Meletios Α. Dimopoulos, Robert A. Kyle, Joan Bladé, Paul G. Richardson, Robert Z. Orlowski, David S. Siegel, Sundar Jagannath, Thierry Façon, Hervé Avet‐Loiseau, Sagar Lonial, Antonio Palumbo, Jeffrey A. Zonder, Heinz Ludwig, David H. Vesole, Orhan Sezer, Nikhil C. Munshi, Jesús F. San Miguel, on behalf of the International Myeloma Workshop Consensus Panel 1 - Blood 2011 被引用: 1,034

  9. Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN): final analysis of an open-label, randomised, phase 2 trial

    著者: Peter M. Voorhees, Douglas W. Sborov, Jacob P. Laubach, Jonathan L. Kaufman, Brandi Reeves, Cesar Rodriguez, Ajai Chari, Rebecca Silbermann, Luciano J. Costa, Larry D. Anderson, Nitya Nathwani, Nina Shah, Naresh Bumma, Yvonne A. Efebera, Sarah A. Holstein, Caitlin Costello, Andrzej Jakubowiak, Tanya M. Wildes, Robert Z. Orlowski, Kenneth H. Shain, Andrew J. Cowan, Shira Dinner, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S. Lin, Saad Z. Usmani, Paul G. Richardson - The Lancet Haematology 2023 被引用: 153

  10. Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial

    著者: Brian G.M. Durie, Antje Hoering, Muneer H. Abidi, S. Vincent Rajkumar, Joshua Epstein, Stephen P. Kahanic, Mohan C. Thakuri, Frederic J. Reu, Christopher M. Reynolds, Rachael Sexton, Robert Z. Orlowski, Bart Barlogie, Angela Dispenzieri - The Lancet 2016 被引用: 888

  11. Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma

    著者: Meletios Α. Dimopoulos, Albert Oriol, Hareth Nahi, Jesús F. San Miguel, Nizar J. Bahlis, Saad Z. Usmani, Neil Rabin, Robert Z. Orlowski, Mieczysław Komarnicki, Kenshi Suzuki, Torben Plesner, Sung‐Soo Yoon, Dina Ben Yehuda, Paul G. Richardson, Hartmut Goldschmidt, Donna Reece, Steen Lisby, Nushmia Z. Khokhar, Lisa O’Rourke, Christopher Chiu, Xiang Qin, Mary Guckert, Tahamtan Ahmadi, Philippe Moreau - New England Journal of Medicine 2016 被引用: 1,434

  12. The BiTE (bispecific T‐cell engager) platform: Development and future potential of a targeted immuno‐oncology therapy across tumor types

    著者: Hermann Einsele, Hossein Borghaei, Robert Z. Orlowski, Marion Subklewe, Gail J. Roboz, Gerhard Zugmaier, Peter Kufer, Karim Iskander, Hagop M. Kantarjian - Cancer 2020 被引用: 231

  13. Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma

    著者: Sagar Lonial, Meletios Α. Dimopoulos, Antonio Palumbo, Darrell White, Sebastian Grosicki, Ivan Špıčka, Adam Walter‐Croneck, Philippe Moreau, María‐Victoria Mateos, Hila Magen, Andrew R. Belch, Donna Reece, Meral Beksaç, Andrew Spencer, Heather Oakervee, Robert Z. Orlowski, Masafumi Taniwaki, Christoph Röllig, Hermann Einsele, Ka Lung Wu, Anil Singhal, Jesús F. San Miguel, Morio Matsumoto, Jessica Katz, Eric Bleickardt, Valerie Poulart, Kenneth C. Anderson, Paul G. Richardson - New England Journal of Medicine 2015 被引用: 1,320

  14. Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group

    著者: Pieter Sonneveld, Hervé Avet‐Loiseau, Sagar Lonial, Saad Z. Usmani, David S. Siegel, Kenneth C. Anderson, Wee Joo Chng, Philippe Moreau, Michel Attal, Robert A. Kyle, Jo Caers, Jens Hillengaß, Jesús F. San Miguel, Niels W.C.J. van de Donk, Hermann Einsele, Joan Bladé, Brian G.M. Durie, Hartmut Goldschmidt, María‐Victoria Mateos, Antonio Palumbo, Robert Z. Orlowski - Blood 2016 被引用: 929

  15. Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma

    著者: Sagar Lonial, Susanna Jacobus, Rafaël Fonseca, Matthias Weiss, Shaji Kumar, Robert Z. Orlowski, Jonathan L. Kaufman, Abdulraheem M. Yacoub, Francis K. Buadi, Timothy O’Brien, Jeffrey Matous, Daniel M. Anderson, Robert Emmons, Anuj Mahindra, Lynne I. Wagner, Madhav V. Dhodapkar, S. Vincent Rajkumar - Journal of Clinical Oncology 2019 被引用: 311

  16. A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib Resistance

    著者: Dharminder Chauhan, Ze Tian, Benjamin Nicholson, Suresh Kumar, Bin Zhou, Ruben D. Carrasco, Jeffrey L. McDermott, Craig A. Leach, Mariaterresa Fulcinniti, Matthew P. Kodrasov, Joseph Weinstock, William D. Kingsbury, Teru Hideshima, Parantu K. Shah, Stéphane Minvielle, Mikael Altun, Benedikt M. Kessler, Robert Z. Orlowski, Paul G. Richardson, Nikhil C. Munshi, Kenneth C. Anderson - Cancer Cell 2012 被引用: 581

  17. Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

    著者: Thierry Façon, Meletios Α. Dimopoulos, Xavier P Leleu, Meral Beksac, Ludek Pour, Roman Hájek, Zhuogang Liu, Jiri Minarik, Philippe Moreau, Joanna Romejko‐Jarosińska, Ivan Spicka, Vladimir Vorobyev, Britta Besemer, Tadao Ishida, Wojciech Janowski, Sevgi Kalayoğlu Beşışık, Gurdeep Parmar, Paweł Robak, Elena Zamagni, Hartmut Goldschmidt, Thomas Martin, Salomon Manier, Mohamad Mohty, Corina Oprea, Marie-France Brégeault, Sandrine Macé, Christelle Berthou, David Bregman, Zandra Klippel, Robert Z. Orlowski - New England Journal of Medicine 2024 被引用: 243

  18. Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial

    著者: Shaji Kumar, Susanna Jacobus, Adam D. Cohen, Matthias Weiss, Natalie S. Callander, Avina K. Singh, Terri L. Parker, Alexander Menter, Xuezhong Yang, Benjamin M. Parsons, Pankaj Kumar, Prashant Kapoor, Aaron S. Rosenberg, Jeffrey A. Zonder, Edward A. Faber, Sagar Lonial, Kenneth C. Anderson, Paul G. Richardson, Robert Z. Orlowski, Lynne I. Wagner, S. Vincent Rajkumar - The Lancet Oncology 2020 被引用: 253

  19. Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma

    著者: Paul G. Richardson, Suzanne Trudel, Rakesh Popat, María‐Victoria Mateos, Annette Juul Vangsted, Karthik Ramasamy, Joaquín Martínez‐López, Hang Quach, Robert Z. Orlowski, Mario Arnao, Sagar Lonial, Chatchada Karanes, Charlotte Pawlyn, Kihyun Kım, Albert Oriol, Jesús G. Berdeja, Paula Rodríguez‐Otero, Ignacio Casas-Avilés, Alessia Spirlì, Jennifer Poon, Shaoyi Li, Jing Gong, Lilly Wong, Manisha Lamba, Daniel W. Pierce, Michael Amatangelo, Teresa Peluso, Paulo Maciag, Jessica Katz, Michael Pourdehnad, Nizar J. Bahlis - New England Journal of Medicine 2023 被引用: 85

  20. Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group

    著者: Michèle Cavo, Evangelos Terpos, Cristina Nanni, Philippe Moreau, Suzanne Lentzsch, Sonja Zweegman, Jens Hillengaß, Monika Engelhardt, Saad Z. Usmani, David H. Vesole, Jesús F. San Miguel, Shaji Kumar, Paul G. Richardson, Joseph Mıkhael, Fernando Leal da Costa, Meletios Α. Dimopoulos, Chiara Zingaretti, Niels Abildgaard, Hartmut Goldschmidt, Robert Z. Orlowski, Wee Joo Chng, Hermann Einsele, Sagar Lonial, Bart Barlogie, Kenneth C. Anderson, S. Vincent Rajkumar, Brian G.M. Durie, Elena Zamagni - The Lancet Oncology 2017 被引用: 520

  21. ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies

    著者: Jo Ishizawa, Kensuke Kojima, Dhruv Chachad, Peter P. Ruvolo, Vivian Ruvolo, Rodrigo Jácamo, Gautam Borthakur, Hong Mu, Zhihong Zeng, Yoko Tabe, Joshua E. Allen, Zhiqiang Wang, Wencai Ma, Hans C. Lee, Robert Z. Orlowski, Dos D. Sarbassov, Philip L. Lorenzi, Xuelin Huang, Sattva S. Neelapu, Timothy J. McDonnell, Roberto N. Miranda, Michael Wang, Hagop M. Kantarjian, Marina Konopleva, R. Eric Davis, Michael Andreeff - Science Signaling 2016 被引用: 202

  22. Acetyl-CoA Synthetase 2: A Critical Linkage in Obesity-Induced Tumorigenesis in Myeloma

    著者: Zongwei Li, Huan Liu, Jin He, Zhiqiang Wang, Zheng Yin, Gichun You, Zhiming Wang, R. Eric Davis, Pei Lin, P. Leif Bergsagel, Elisabet E. Manasanch, Stephen T.C. Wong, Nestor F. Esnaola, Jenny C. Chang, Robert Z. Orlowski, Qing Yi, Jing Yang - Cell Metabolism 2021 被引用: 106

  23. Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial

    著者: Meletios Α. Dimopoulos, Albert Oriol, Hareth Nahi, Jesús F. San Miguel, Nizar J. Bahlis, Saad Z. Usmani, Neil Rabin, Robert Z. Orlowski, Kenshi Suzuki, Torben Plesner, Sung‐Soo Yoon, Dina Ben Yehuda, Paul G. Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Philippe Moreau - Journal of Clinical Oncology 2023 被引用: 128

  24. A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

    著者: Paul G. Richardson, Bart Barlogie, James R. Berenson, Seema Singhal, Sundar Jagannath, David Irwin, S. Vincent Rajkumar, Gordan Srkalović, Melissa Alsina, Raymond Alexanian, David S. Siegel, Robert Z. Orlowski, David J. Kuter, Steven Limentani, Stephanie J. Lee, Teru Hideshima, Dixie‐Lee Esseltine, Michael Kauffman, Julian Adams, David P. Schenkein, Kenneth C. Anderson - New England Journal of Medicine 2003 被引用: 2,641